Ann-Katrin Hopp
Impact in
- Physiology top 5%
- Calcium signaling and nucleotide metabolism
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
- Oncology 12
- PARP inhibition in cancer therapy 9
- Drug Transport and Resistance Mechanisms 2
-
- Calcium signaling and nucleotide metabolism 5
- Co-authors
- Michael O. Hottiger (13 shared papers)Kathrin Nowak (4 shared papers)Sen Cheng (2 shared papers)Wenqing Gao (2 shared papers)Jingjin Ding (2 shared papers)Yue Xu (1 shared paper)Xiaoyun Liu (1 shared paper)Xuyan Shi (2 shared papers)
- Journals
- Cells (2 papers)Nature Communications (2 papers)Molecular Cell (2 papers)iScience (1 paper)Life Science Alliance (1 paper)
- Partner nations
- SwitzerlandGermanyAustria
In The Last Decade
Ann-Katrin Hopp
22 papers receiving 884 citations
Ann-Katrin Hopp's Hit Papers
Peers
Comparison fields: 5 of 89
- Physiology 116
- Geriatrics and Gerontology 66
- Immunology 225
- Endocrinology 55
- Clinical Biochemistry 46
Countries citing papers authored by Ann-Katrin Hopp
This map shows the geographic impact of Ann-Katrin Hopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann-Katrin Hopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann-Katrin Hopp more than expected).
Fields of papers citing papers by Ann-Katrin Hopp
This network shows the impact of papers produced by Ann-Katrin Hopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann-Katrin Hopp. The network helps show where Ann-Katrin Hopp may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann-Katrin Hopp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Bacterial Effector Reveals the V-ATPase-ATG16L1 Axis that Initiates Xenophagy Hit paper breakdown → | 2019 | 299 |
| 2 | 2019 | 81 | |
| 3 | 1980 | 72 | |
| 4 | 2018 | 61 | |
| 5 | 2017 | 58 | |
| 6 | 2021 | 53 | |
| 7 | 2020 | 47 | |
| 8 | 1984 | 46 | |
| 9 | 2014 | 46 | |
| 10 | 2023 | 29 | |
| 11 | 2021 | 27 | |
| 12 | 2019 | 26 | |
| 13 | 2023 | 23 | |
| 14 | 2016 | 10 | |
| 15 | 1979 | 9 | |
| 16 | 2024 | 6 | |
| 17 | 2025 | 4 | |
| 18 | 2018 | 3 | |
| 19 | 2021 | 3 | |
| 20 | 2025 | 3 |
About Ann-Katrin Hopp
Ann-Katrin Hopp is a scholar working on Oncology, Physiology, Geriatrics and Gerontology, Immunology and Molecular Biology, having authored 24 papers that have together received 909 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (9 papers), Calcium signaling and nucleotide metabolism (5 papers), Sirtuins and Resveratrol in Medicine (3 papers), CRISPR and Genetic Engineering (2 papers), Autophagy in Disease and Therapy (2 papers), DNA Repair Mechanisms (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Physiology (116 citations), Geriatrics and Gerontology (66 citations), Immunology (225 citations), Endocrinology (55 citations) and Clinical Biochemistry (46 citations). Ann-Katrin Hopp has collaborated with scholars based in Switzerland, Germany and Austria. Frequent co-authors include Michael O. Hottiger, Kathrin Nowak, Sen Cheng, Wenqing Gao, Jingjin Ding, Yue Xu, Xiaoyun Liu, Xuyan Shi, Ping‐Kun Zhou and Lin Li. Their work appears in journals such as Cells, Nature Communications, Molecular Cell, iScience and Life Science Alliance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.